Purpose: To obtain pilot data on posture-induced changes of intraocular pressure (IOP), systemic pressure, and pattern electroretinogram (PERG) predictive of future optic nerve tissue loss glaucoma suspects (GSs).
A central yet unresolved issue in open-angle glaucoma is determining, in individual subjects, the onset of the disease. This may be defined as the stage at which retinal ganglion cells become susceptible to a stressful environment and dysfunctional. 1 Thus, identifying retinal ganglion cell dysfunction before manifest glaucoma would represent the ideal time window for initiating therapeutic strategies to prevent cell death and visual loss.
Risk assessment 2 in patients with suspicion of glaucoma may provide an evidence-based rationale for timely treatment to prevent development of the disease. Risk assessment may be potentiated by the use of provocative tests. [3] [4] [5] [6] It is well known that head-down posture results in changes of the intraocular and systemic pressures that may be associated with a variety of ocular manifestations and visual loss whose severity depends on the angle of tilt and the duration of head-down posture. [7] [8] [9] [10] [11] [12] Even a temporary head-down posture with small angle of tilt may induce reversible loss of neurophysiological function in normal subjects at both the retinal and cortical level. 13, 14 Ventura et al 15 using a head-down body tilt (HDT) of À 10 degrees below supine orientation for 8 minutes, reported reversible pattern electroretinogram (PERG) losses in a subpopulation of glaucoma suspects (GSs) that was associated with intraocular pressure (IOP) and systemic pressure elevation. 15 Thus, temporary, moderate head-down posture can be potentially used as provocative test to identify GSs that may develop glaucoma earlier than those less susceptible to the procedure. Here, we show in a population of GS, longitudinally monitored with optical coherence tomography (OCT) over an average of 5 years, that baseline PERG and systemic/ocular pressures, together with their changes upon head-down posture, may predict future loss of nerve retinal fiber layer thickness (RNFLT).
METHODS

Subjects
Study subjects were 28 GS (mean age, 58 ± 8.9 y at baseline) that were part of a longitudinal cohort of 107 patients monitored 2 times per year over at least 4 years (mean 5.0 ± 0.73 y) with PERG and OCT. 16 The present subgroup of 28 patients represented all GS who also received 1 PERG, IOP, and hemodynamic assessment in the seated and HDT posture during the first year of the follow-up. 15 An additional group of 11 similarly aged healthy controls (SAC, mean age, 56.9 ± 13 y, difference with study subjects, P = 0.3) originating from a previous study 15 was used to compare PERG, IOP, and hemodynamic parameters upon HDT with the study group.
Study patients were enrolled as GSs at their initial visit based on detailed medical and ocular history, and a comprehensive eye examination as described previously. 17 Subjects met the following inclusion criteria: refractive errors within À 5 to + 3 D, best-corrected visual acuityZ20/20 (Snellen), normal standard automated perimetry according to the Ocular Hypertension Treatment Study (OHTS) criteria 18 (reliability < 33% on all indices, normality > 5% on all global indices in two consecutive sessions 6 mo apart), and glaucomatous optic disc appearance (vertical cup-to-disc ratio > 0.5; vertical cup-to-disc ratio asymmetryZ0.2, localized thinning of the disc, splinter disc hemorrhages) or IOP > 21 mm Hg. At least one eye meeting the inclusion criteria qualified a patient as GS, although none of the study patients had elevated IOP. For all subjects, exclusion criteria were age-related macular degeneration, high myopia (> 5 D), uveitis, diabetes, Parkinson disease, multiple sclerosis, and the presence of any other ocular or systemic disease that may cause nonspecific PERG abnormalities. Patients with history of previous intraocular surgery were also excluded. None of the patients had history of, or took medications for, systemic hypertension/peripheral vascular disease/cardiac disease. Baseline characteristics of patients are summarized in Table 1 .
Enrolled patients were followed with PERG and OCT for at least 4 years with 6 or more visits during this period. Some patients (13/28) received treatment during follow-up (5 in year 1; 3 in year 2; and 5 in year 3). Initiation of therapy was based on the patients' increased awareness of their condition and concern for the associated risks that was discussed with the clinician, eventually resulting in the initiation of treatment. 19 Treatment consisted of either prostaglandin analogs (n = 12) or b blockers (n = 1) (American Academy of Ophthalmology Preferred Practice Pattern, Glaucoma Panel, Hoskins Center for Quality Eye Care, available in the public domain at http://www.aao. org/ppp). The study followed the tenets of the Declaration of Helsinki and was approved by the Institutional Review Board of the University of Miami. Informed written consent was obtained from all subjects after the nature of the test and possible risks were explained in detail.
Body Tilt Equipment
The equipment for PERG recording at different positions of body posture has been previously described in detail. 15 Briefly, the PERG apparatus was incorporated in a custom-built balanced frame that rotated in sync with an electronically adjustable surgical bed. A moderate (À 10 degrees) HDT angle was chosen based on previous pilot data 20 to induce a measurable, transient IOP elevation while minimizing potential risks of undesirable systemic hemodynamic reactions in patients. 21, 22 The equipment also allowed measurement of IOP at designated postures (seated baseline, HDT, seated recovery) as well as measure of brachial arterial pressure.
Experimental Protocol
The experimental protocol has been previously described in detail. 15 Briefly, IOP, blood pressure, and PERG were first recorded in sequence with the subjects in the seated position (baseline). Subjects' posture was then progressively (over 1 min) changed to À 10 degrees HDT. IOP, blood pressure and PERG were measured again in the time window 3 to 8 minutes after posture change. On the basis of previous reports, a moderate head-down tilt produces a rapid (within 1 min) elevation of IOP that persists for at least 30 minutes. 13 Finally, subjects were adjusted back to seated position (recovery) within 1 minute and all measurements repeated. PERG and pressure parameters in the recovery position are not displayed in the present study, as they were previously shown to be not significantly different from the seated baseline condition. 15 
PERG Recording
We used a recording paradigm optimized for glaucoma detection (PERGLA) incorporated in a commercial system (Lace Elettronica, Rome, Italy). Details of the technique have been previously reported. 15, 23 The PERG was simultaneously recorded from both eyes by means of skin electrodes taped on the lower eyelids. Reproducibility of measurements using this protocol is considered to be very good and suitable for monitoring changes over time. [24] [25] [26] Intratest variability of amplitude and phase is similar between normal controls and GSs, and does not change between the seated and HDT conditions. 15 As the PERG was recorded in response to a fast contrast-reversal (16.28 reversals/s) stimulus, response waveforms were typically sinusoidal-like, with a temporal period corresponding to the reversal rate. PERG waveforms were automatically analyzed in the frequency domain by Discrete Fourier Transform to isolate the frequency component at the contrast-reversal rate (16.28 Hz), and compute its peak amplitude in microVolt and phase in p radians. Decreasing phase values are analog to latency delays (31 ms/1.0 p rad).
OCT Recording
Peripapillary mean RNFLT was evaluated using the fast RNFL program of the Stratus OCT (Carl Zeiss Meditec, Dublin, CA), and analyzed using software version 3.0. OCT measurements were performed with signal strength of 7 or higher. RNFLT was determined at 256 points of a circular scan (diameter 3.4 mm) centered on the center of the optic disc that was repeated 3 consecutive times at each visit, exported on an electronic worksheet, and an average scan was computed. Mean RNFLT was evaluated from the average scan as previously described. 27 
IOP Measurement
IOP was measured with a portable, noncontact, air pulse tonometer (Reichert PT100, Depew, NY) for all conditions. For each IOP reading, the instrument calculates the average of 3 consecutive measures. Portable, noncontact tonometry allowed measurements in HDT position and also prevented the formation of corneal irregularities that can be generated by repeated readings with contact tonometers. Corneal surface irregularities produce scatter that degrade the stimulus contrast 28 and may reduce PERG amplitude. 29 Air pulse tonometers yield IOP values that are reproducible and comparable with those obtained with Goldmann applanation tonometry. [30] [31] [32] 
Systemic Pressure Measurements
Systemic blood pressure (brachial artery) was assessed with a Welch-Allyn Vital Sign Monitor 300 Series (Skaneateles Falls, NY). For each body position, mean arterial blood pressure (MAP) was calculated from diastolic blood pressure (DBP) and systolic blood pressure (SBP) according to the formula MAP = DBP + 0.42Â(SBPÀ DBP). 33, 34 Ocular perfusion pressure (OPP) was defined as the difference between mean central artery pressure (MCAP) and IOP: OPP = MCAPÀIOP. 35, 36 The MCAP is linked to the MAP by a posture coefficient, as the hydrostatic effect of the blood column between the heart and the eye depends on posture. 35, 36 On the basis of ophthalmodynamometric measurements of the MCAP obtained at different body positions and extrapolated to derive the posture coefficient in the seated position and at À10 degrees HDT, OPP seated was = (MAPÂ 0.74)ÀIOP, and OPP tilted was = (MAPÂ0.86)ÀIOP. 15, 33, 34, 37, 38 
Statistics
The criterion for mean RNFL thinning beyond chance was obtained from published data by Budenz et al 39 using the method detailed in the appendix of that publication. In brief, the first 3 measurements and the 3 last measurements of the follow-up series were averaged, and their difference represented the RNFL change, a conservative approach to minimize sampling variability. The test-retest tolerance limit for mean RNFLT (table 2 of Budenz et al 39 ) was multiplied by the square root of 2/3 obtaining 5.4 mm as a 2-sided change in RNFLT beyond chance. This value is >4 times the rate of normal age-related mean RNFL thinning. 40 Logistic regression was used to create a prediction equation for the risk of RNFL thinning (> 5.4 mm from baseline to follow-up) in which PERG and hemodynamic measurements at baseline and change upon HDT were allowed entry in a backward stepwise fashion. In this pilot study, we relaxed the P-value for inclusion in the model to 0.2 as recommended as a model building strategy. 41 One randomly selected eye from each participant was included in this analysis. Both selected eyes and contralateral eyes met the study criteria for GS.
RESULTS
A Subpopulation of GS Displayed Significant Mean RNFL Thinning After 5 Years Figure 1 compares baseline RNFL mean thicknesses with corresponding changes for randomly selected eyes of 28 GS patients monitored 5.0 ± 0.73 years. Changes larger than 5.4 mm significantly (P < 0.05) exceed the intervisit test-retest variability criterion for mean RNFLT changes. 39 In our GS patient population, eyes with reduction of mean RNFLT larger than 5.4 mm (9/28, 32%) have been defined as "thinners, T", as opposed to "nonthinners, NT" that had changes ± 5.4 mm. The mean loss of RNFLT in T was À8.18 mm (SE, 1.02), whereas in NT was À 0.685 mm (SE, 0.687). Both T and NT had baseline RNFLT in the normal range 42 with no significant difference between them (t test, P = 0.21). Also, in both T and NT the baseline RNFLT was not correlated with RNFLT change (T: R 2 = 0.014; NT, R 2 = 0.026). To corroborate Budenz et al 39 criterion of significant thinning, we performed linear regression analysis of the mean RNFLT over age [43] [44] [45] Changes of mean RNFLTs overB5 years in randomly selected eyes of 28 glaucoma suspects. Initial and final RNFLTs were the average of first 3 and last measurements of the longitudinal series, respectively. Note that 9/28 eyes had losses of RNFLT larger than 5.4 mm, which represents the ± 95% confidence interval of the normal intervisit test-retest variability of mean RNFLT according to Budenz et al. 39 In both thinners (T) and the nonthinners (NT), the initial mean RNFLT was in the normal range according to Budenz et al. 42 In both T and the NT, there was no significant correlation between initial RNFLT and change of RNFLT (NT, R 2 = 0.026; T, R 2 = 0.014). Thirteen patients (red symbols) received intraocular pressure-lowering drops during the follow-up period. Figure 1 can be viewed in color online at www.glaucomajournal.com. Figure 2A compares PERG amplitude of similarly aged controls (SACs), NT, and T in the seated position and during HDT posture. Univariate analysis of variance (ANOVA) did not reveal a significant difference among groups in the seated position (P = 0.08). In the tilted position, however, there was a significant (P = 0.0025) difference between groups (SAC > NT, P = 0.001; SAC > T, P = 0.0075). A 2-way repeated measures ANOVA of factors group (SAC, NT, and T) and posture (seated, HDT) on the dependent-variable PERG amplitude revealed that there was a significant effect of group (P = 0.0098), posture (P < 0.001), and an interaction between group and posture (P = 0.02).
Baseline PERG Amplitude and Phase and Their Changes Upon HDT
Univariate ANOVA of PERG phase (Fig. 2B) showed that there was a significant (P = 0.019) difference among groups in the seated position (SAC > NT, P = 0.043; SAC > T, P = 0.0052). In the tilted position, there was no significant difference among groups (P = 0.19). A 2-way repeated measures ANOVA of PERG phase showed that there was a significant effect of group (P = 0.03), but no effect of tilt (P = 0.21) or interaction between group and posture (P = 0.87). Figure 3A compares IOP of SAC, NT, and T groups during seated and HDT posture. Univariate ANOVAs did not show group differences in both seated and HDT posture. However, a 2-way repeated measures ANOVA of factors group and posture revealed a strong effect of posture (P < 0.001). In all subjects' groups there were significant (Pr 0.01) IOP elevations upon HDT posture (SAC: + 3.72 mm Hg; NT: + 3.7 mm Hg; T: + 4.04 mm Hg). Figure 3B compares MAP of SAC, NT, and T groups during seated and HDT postures. Univariate ANOVAs showed that there was a significant (P = 0.035) difference among groups in the HDT posture (SAC < T, P = 0.0109). A 2-way repeated measures ANOVA of factors group and posture revealed that there was a significant (P = 0.046) effect of posture but no interaction between group and posture. , and RNFL thinners (T, n = 9). Bars represent the mean and the SEM. Note in A that IOP increases in all groups upon head-down-body-tilt (HDT). Also note in B and C that MAP and OPP tend to be higher in the T group compared with NT and SACs. Note in C that OPP tends to increase upon HDT in NT and T but not in controls. Figure 3 can be viewed in color online at www.glaucomajournal.com. Figure 3C compares OPP of SAC, NT, and T groups during seated and HDT posture. Univariate ANOVAs showed significant (P = 0.0093) group differences in the HDT posture (SAC < T, P = 0.0024). A 2-way repeated measures ANOVA of factors group and posture revealed a significant effect of group (P = 0.048) a strong effect of posture (P < 0.001), as well as a strong interaction between group and posture (P < 0.001). There were significant (Pr 0.01) OPP elevations upon HDT posture in NT (+ 6.96 mm Hg) and T (+ 7.83 mm Hg) groups but not in the SAC group.
Baseline Systemic and Ocular Pressures and their Changes Upon HDT
Baseline PERG and Systemic/Ocular Pressures as Predictor of RNFL Thinning
As both PERG and systemic/ocular pressures showed baseline and posture-dependent changes in T and NT, we performed a multivariate statistical analysis to understand if RNFL thinning could be predicted based on baseline variables. Backwards stepwise logistic regression isolated 4 relevant variables (PERG amplitude seated, PERG phase seated, PERG phase HDT, and MAP HDT). Corresponding coefficients of the logistic regression equation are summarized in Table 2 .
The logistic regression determined a prediction equation able to discriminate (P = 0.007) eyes with RNFL thinning from eyes with unchanged RNFL with an area under the receiving operator characteristic (ROC) curve of 0.89 (SE, 0.07). This estimate was obtained using the same data from which the model was constructed. In Figure 4 the PERG variable (a linear combination of seated PERG amplitude/phase and PERG phase upon HDT) is plotted against MAP upon HDT. The separation graph between T and NT displayed in Figure 4 shows that T appear to be separated from NT by diagonal line with 1 false negative and 5 false positives. We did not have an independent validation sample; however, repeating the logistic regression on the eyes nonselected for randomization discriminated eyes with RNFL thinning from eyes with unchanged RNFL with an area under the ROC curve of 0.833, SE, 0.087 (Supplementary Figure S1 ,Supplemental Digital Content 1, http://links.lww.com/IJG/A114).
Retrospective Analysis of Baseline Clinical Characteristics of T and NT
A relevant question to ask was whether RNFL thinning could have been predicted based on the baseline risk profile of patients. Retrospective analysis of baseline characteristics summarized in Table 3 shows that 5/9 (55%) of T and 8/19 (42%) of NT received treatment during the follow-up period. The difference in the frequency of treatment between the 2 groups was not statistically significant (P = 0.13, Fisher exact test). T, compared with NT, were relatively older, had a thinner cornea, a larger disk cupping, thinner RNFL, and worse visual field mean deviation/ pattern SD. However, these differences were small and not statistically significant. There was no significant correlation between CCT and RNFLT in T (R = 0.33, P = 0.39). The calculated OHTS risk score (http://ohts.wustl.edu/risk/cal culator.html) also was relatively higher in T versus NT but the difference not statistically significant. According to the OHTS risk calculator, the risk of developing glaucoma after 5 years was similar in T (14.4 ± 4.4%) and in NT (13.5% ± 4.1%).
Overall, retrospective analysis of baseline risk profile was consistent with the prediction of RNFL thinning based on HDT-induced neurovascular changes, but was per se insufficient to predict T from NT.
DISCUSSION
This longitudinal study on 28 GSs shows that 9/28 of them developed significant mean RNFL thinning over 5 years while 19/28 did not. Both T and NT had normal RNFL thickness at baseline, and in both groups the magnitude of RNFL change was unrelated to baseline RNFLT. The rate of change of mean RNFLT in the group of T (À 0.164 mm/y) was in the range of that reported by Miki et al 44 (mean À 2.02 mm/y) for GSs eventually developing visual field damage. However, none of the RNFL T in the present study developed visual field defects over the observation period.
The present study showed that both RNFL T and NT, compared with SACs, had significantly lower tilted PERG amplitude and delayed seated PERG phase. Previous cross- sectional results of our group 15 also demonstrated posturedependent PERG losses in GSs. T also had significantly higher MAP and estimated OPP compared with controls. Combining PERG variables with hemodynamic variables for randomly selected eyes at different posture in a logistic regression model predicted T from NT with an area under the ROC curve of 0.89 (P = 0.007). To ensure that the results were consistent, analyses were repeated on the eyes not originally selected with similar results. This represents a novel and potentially important finding, as assessment of posture-dependent neurovascular variables may potentiate risk assessment in the clinical management of glaucoma. We retrospectively compared baseline risk factors between T and NT. A few of these variables (Table 3) showed borderline significant (0.1 > P > 0.05) differences between the 2 groups, but were not themselves sufficient to discriminate between T and NT. According to the OHTS risk calculator, the risk of developing glaucoma after 5 years was similar in T (14.4%) and in NT (13.5%).
Although the present study suggests that posturedependent neurovascular variables have predictive value on future RNFL thinning, it does not provide clear insights about the corresponding causative mechanisms. Body inversion is known to be associated with a host of manifestations relevant to glaucoma, including IOP elevation, increased pressure of the central retinal artery and of the cerebrospinal fluid, vasoconstriction of the retinal arterioles, and orbital congestion. 8, 33, 35, 36, [46] [47] [48] [49] [50] Body inversion is also known to be associated with optic nerve dysfunction as shown by loss of PERG signal, 13,14 loss of VEP signal, 7, 14 as well as loss of psychophysical visual function. 11 Prolonged head-down posture may cause irreversible ischemic damage in the optic nerve. 12 This study has some limitations that need to be pointed out. First, the patients' sample was small. Second, some of the patients were treated during the follow-up. IOP-lowering treatment may improve PERG amplitude 51 and alleviate the magnitude of RNFL thinning. Although IOP-lowering-dependent PERG amplitude improvement does not represent an issue as treatment was initiated after baseline PERG data were collected, IOP-lowering-dependent alleviation of RNFL thinning might have changed the status of some patients with borderline significant RNFL thinning from T to NT. This however, was unlikely the case as Figure 1 shows that borderline NT were not treated. As treatment was administered in both T and NT, treatment did not significantly contribute to the logistic regression model. Third, the logistic regression model did not have an independent validation sample; however, logistic regression analysis on measurement of fellow eyes gave similar results. Fourth, RNFLT data were obtained with Stratus OCT that was available when the study was initiated; Stratus OCT had insufficient lateral resolution for detailed focal RNFL analysis. We cannot exclude that assessment of the region of maximal thinning with a current state-of-the-art OCT instrument might have produced somewhat different results.
Altogether, this study provides promising pilot data for a full-scale clinical trial to test the hypothesis that a HDT provocative test may help to potentiate risk assessment in GSs. A randomized clinical trial (NCT02390284), including HDT provocation in GSs has been initiated at Bascom Palmer Eye Institute. 
